Synthesis, molecular properties prediction and biological evaluation of indole-vinyl sulfone derivatives as novel tubulin polymerization inhibitors targeting the colchicine binding site

被引:37
作者
Li, Wenlong [1 ,2 ]
Sun, Honghao [1 ,2 ]
Xu, Feijie [1 ,2 ]
Shuai, Wen [1 ,2 ]
Liu, Jie [1 ,2 ]
Xu, Shengtao [1 ,2 ]
Yao, Hequan [1 ,2 ]
Ma, Cong [3 ,4 ]
Zhu, Zheying [5 ]
Xu, Jinyi [1 ,2 ]
机构
[1] China Pharmaceut Univ, State Key Lab Nat Med, 24 Tong Jia Xiang, Nanjing 210009, Jiangsu, Peoples R China
[2] China Pharmaceut Univ, Dept Med Chem, 24 Tong Jia Xiang, Nanjing 210009, Jiangsu, Peoples R China
[3] Hong Kong Polytech Univ, State Key Lab Chem Biol & Drug Discovery, Kowloon, Hong Kong, Peoples R China
[4] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Kowloon, Hong Kong, Peoples R China
[5] Univ Nottingham, Sch Pharm, Div Mol Therapeut & Formulat, Univ Pk Campus, Nottingham NG7 2RD, England
基金
中国国家自然科学基金;
关键词
Tubulin inhibitor; Vinyl sulfone; Indole; Colchicine site; Drug-likeness; ANTINEOPLASTIC AGENTS; ANTICANCER AGENTS; ANTITUMOR AGENTS; IN-VITRO; DISCOVERY; TACRINE; UPDATE; A-4;
D O I
10.1016/j.bioorg.2018.12.015
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Twenty-two novel indole-vinyl sulfone derivatives were designed, synthesized and evaluated as tubulin polymerization inhibitors. The physicochemical and drug-likeness properties of all target compounds were predicted by Osiris calculations. All compounds were evaluated for their antiproliferative activities, among them, compound 7f exhibited the most potent activity against a panel of cancer cell lines, which was 2-7 folds more potent than our previously reported compound 4. Especially, 7f displayed about 8-fold improvement of selective index as compared with compound 4, indicating that 7f might have lower toxicity. Besides, 7f inhibited the microtubule polymerization by binding to the colchicine site of tubulin. Further investigations showed that compound 7f effectively disrupted microtubule network, caused cell cycle arrest at G2/M phase and induced cell apoptosis in K562 cells. Moreover, 7f reduced the cell migration and disrupted capillary-like tube formation in HUVEC cells. Importantly, the in vivo anti-tumor activity of 7f was validated in H22 liver cancer xenograft mouse model without apparent toxicity, suggesting that 7f is a promising anti-tubulin agent for cancer therapy.
引用
收藏
页码:49 / 59
页数:11
相关论文
共 34 条
[1]   Quinazoline-tyrphostin as a new class of antitumor agents, molecular properties prediction, synthesis and biological testing [J].
Alafeefy, Ahmed M. ;
Alqasoumi, Saleh I. ;
Ashour, Abdelkader E. ;
Masand, Vijay ;
Al-Jaber, Nabila A. ;
Ben Hadda, Taibi ;
Mohamed, Menshawy A. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2012, 53 :133-140
[2]   TACRINE - 1ST DRUG APPROVED FOR ALZHEIMERS-DISEASE [J].
CRISMON, ML .
ANNALS OF PHARMACOTHERAPY, 1994, 28 (06) :744-751
[3]   Tubulin structure: insights into microtubule properties and functions [J].
Downing, KH ;
Nogales, E .
CURRENT OPINION IN STRUCTURAL BIOLOGY, 1998, 8 (06) :785-791
[4]   Synthesis of triazoloquinazolinone based compounds as tubulin polymerization inhibitors and vascular disrupting agents [J].
Driowya, Mohsine ;
Leclercq, Julien ;
Verones, Valerie ;
Barczyk, Arnelie ;
Lecoeur, Marie ;
Renault, Nicolas ;
Flouquet, Nathalie ;
Ghinet, Alina ;
Berthelot, Pascal ;
Lebegue, Nicolas .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 115 :393-405
[5]   Microtubule-binding agents: a dynamic field of cancer therapeutics [J].
Dumontet, Charles ;
Jordan, Mary Ann .
NATURE REVIEWS DRUG DISCOVERY, 2010, 9 (10) :790-803
[6]   Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties [J].
Ertl, P ;
Rohde, B ;
Selzer, P .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (20) :3714-3717
[7]   Blocking Blood Flow to Solid Tumors by Destabilizing Tubulin: An Approach to Targeting Tumor Growth [J].
Jesus Perez-Perez, Maria ;
Priego, Eva-Maria ;
Bueno, Oskia ;
Martins, Maria Solange ;
Canela, Maria-Dolores ;
Liekens, Sandra .
JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (19) :8685-8711
[8]   Microtubules as a target for anticancer drugs [J].
Jordan, MA ;
Wilson, L .
NATURE REVIEWS CANCER, 2004, 4 (04) :253-265
[9]   A comprehensive listing of bioactivation pathways of organic functional groups [J].
Kalgutkar, AS ;
Gardner, I ;
Obach, RS ;
Shaffer, CL ;
Callegari, E ;
Henne, KR ;
Mutlib, AE ;
Dalvie, DK ;
Lee, JS ;
Nakai, Y ;
O'Donnell, JP ;
Boer, J ;
Harriman, SP .
CURRENT DRUG METABOLISM, 2005, 6 (03) :161-225
[10]   Recent developments in tubulin polymerization inhibitors: An overview [J].
Kaur, Ramandeep ;
Kaur, Gurneet ;
Gill, Rupinder Kaur ;
Soni, Richard ;
Bariwal, Jitender .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2014, 87 :89-124